Viewing Study NCT01206361


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-03-12 @ 3:38 PM
Study NCT ID: NCT01206361
Status: COMPLETED
Last Update Posted: 2021-02-02
First Post: 2010-08-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A6111145
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators